The increasing set of liver-directed therapies (LDT) have become an integral part of
hepatocellular carcinoma (HCC) treatment. These range from percutaneous ablative …

The production of novel radionuclides is the first step towards the development of new
effective radiopharmaceuticals, and the quality thereof directly affects the preclinical and …

Primary liver cancer includes hepatocellular carcinoma (HCC, 75–85%) and intrahepatic
cholangiocarcinoma (10–15%). The vast majority of patients with primary HCC are not …

Purpose To investigate clinical feasibility, technical success and toxicity of 166 Ho-
radioembolization (166 Ho-RE) as new approach for treatment of hepatocellular carcinomas …

Background This retrospective analysis was undertaken to evaluate the efficiency of SIRT
with Y-90 microspheres and determined prognostic factors affecting patients with …

Simple Summary The usefulness of transarterial radioembolization (TARE) as a treatment
has been endorsed by different authors and recommended by a multidisciplinary working …

With the increasing incidence of hepatocellular carcinoma (HCC) and its high mortality rates,
effective treatment options are of urgent need, preferably in a multidisciplinary setting. In the …

Background Hepatocellular carcinoma (HCC) is subject to different management
approaches and guidelines according to Eastern and Western therapeutic algorithms. Use …

Purpose To evaluate the feasibility of a same-day yttrium-90 (90 Y) radioembolization
protocol with resin microspheres (including pretreatment angiography, lung shunt fraction …

PURPOSE: The recent sorafenib versus radioembolization in advanced hepatocellular
carcinoma (SARAH) and selective internal radiation therapy versus sorafenib in locally …